KYTX Appoints Nadia Dac as CCO, 30Y Exp, Launches miv-cel for Stiff Person Syndrome, $300K Inducement Option
Kyverna Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $8.22
+20% in 7d after detection
Post-detection moves
1h
—
1d
+2.3%
3d
+3.3%
7d
+20%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS